Brenntag Se · XETR:BNR
Brenntag — Q2 2024 Earnings Presentation
28 slides from Brenntag's earnings presentation, August 2024
Slide 1: Brenntag
> BRENNTAG 1 > Oia
Slide 2: Q2 2024 Results Presentation: Highlights
Q2 2024 Results 1. Highlights Q2 2024 Presentation
Slide 3: Highlights Q2 2024
Highlights Q2 2024 SALES EUR 4.2 bn - 2.0% vs. PY (fx adj.) EPS EUR 1.03 Q2 2023: EUR 1.23 OPERATING GROSS PROFIT EUR 1,028 m + 0.6% vs. PY (Fx adj.) BUSINESS ENVIRONMENT Intense competition Initiatives to stabilize margins well underway OPERATING EBITA EUR 297 m - 10.4% vs. PY (fx adj.) STRATEGY EX
Slide 4: Update on our strategic initiatives
Update on our strategic initiatives M&A Sustainability Strategy update Feitiong!) . b 5 acquisitions» (YTD Aug 13, 2024): puarnum DX Corporate ESG Performance = Fully committed to execute our Strategy | BES | BSP RATED BY = Continuously increasing divisional ba Q DELTA ISS ESG> autonomy and independ
Slide 5: 2. Financial performance Q2
Q2 2024 Results Presentation 2. Financial performance Q2 2024
Slide 6: Operating EBITA bridges
Financials Q2 2024: Operating EBITA bridges” Operating EBITA growth in EURm - 10% 4 Lal -42 Q2 2023 FX translation M&A Organic Q2 2024 contribution growth FX translation A 6 Hi M&A contribution Operating EBITA growth by division inEURm -10% | -13% -13% E 2, Q2 2023 Brenntag Brenntag Group and Specia
Slide 7: Brenntag Specialties
Financials Q2 2024: Brenntag Specialties Operating EBITA growth vs. PY Results impacted by negative Gross Profit per unit development while volumes were above prior-year period Life Science Material Science Operating Gross Profit of EUR 298 million, stable 0.1% vs. PY -13.8% -7.5% 9) Operating EBITA
Slide 8: Brenntag Essentials
Financials Q2 2024: Brenntag Essentials Operating EBITA growth vs. PY Positive volume developments were able to offset lower gross profit per unit in most regions NORTH AMERICA EMEA Operating Gross Profit of EUR 730 million, an increase of 0.8 % vs. PY q 9, cq 0, 4.7 Yo 17.9 %o Operating EBITA of EU
Slide 9: Income statement
Financials Q2 2024: Income statement in EURMm Q22023 A AFX adjusted Sales 4,176.3 4,256.6 -1.9% -2.0% Cost of materials -3,147.2 -3,235.8 -2.7% - 1,027.9 1,020.8 0.7% 0.6% Operating expenses -641.9 -611.1 5.0% 5.3% 386.0 409.7 5.8% 5.7% Depreciation -88.9 -77.5 14.7% 14.4% 297.1 332.2 -10.6% -10.4%
Slide 10: OPEX bridge
Financials Q2 2024: OPEX bridge” Operating expense development inEURm 5.3% i: i: Q2 2023 FX M&A, underl. OPEX Other Q2 2024 translation DiDEX & IT effects FX translation Hl M&A, DiDEX & IT Ml underl. OPEX Other effects (A 10. 2Calcutations are partly based on assumptions made by management; effects
Slide 11: Free cash flow
Financials Q2 2024: Free cash flow in EURm 022028 Aabs. Payments to acquire intangible assets and property, plant and equipment -76.1 -61.1 -24.0 A Working capita -108.1 110.8 -218.9 Principal and interest payments on lease liabilities -45.3 -37.7 -7.6 Free cash flow 157.5 431.7 -274.2 Working capit
Slide 12: Balance sheet and maturity profile
Financials Q2 2024: Balance sheet and maturity profile in EURm KURT Pye 31 Dec 2023 Financial liabilities 2,952.4 Lease liabilities 569.7 ./. Cash and cash equivalents 657.8 Net Debt 2,864.3 Equity 4,427.5 2,313.9 449.8 576.9 2,186.8 14x 4,356.7 Eurobond & in EUR m?) Promissory Note Eurobond & Eurob
Slide 13: 3. Outlook
Q2 2024 Results Presentation 3. Outlook
Slide 14: Outlook 2024
Outlook 2024: Markets will remain highly competitive Operating (@) EBITA Guidance Macro environment @ 1 Additional information (OGM) oreecetickesnocecenntscorcttonata earnings from acquisitions already closed and assumes stable fx-rates at the time of the guidance announcement Brenntag expects opera
Slide 15: Dr. Christian Kohlpaintner CEO, Dr. Kristin Neumann CFO
Dr. Christian Kohlpaintner Dr. Kristin Neumann CEO CFO
Slide 16: 4. Appendix
Q2 2024 Results Presentation 4. Appendix
Slide 17: Segments
Financials Q2 2024: Segments inEURm Specialties Life Science 205.5 Specialties Material Science 87.1 Specialties Other 49 Essentials EMEA 261.4 Essentials North America 397.0 Essentials Latin America 40.1 Essentials APAC 38.2 Essentials Transregional 3.7 Aw Operating Gross Profit) Q2 2023 206.4 88.2
Slide 18: Cash flow statement
Financials Q2 2024: Cash flow statement Profit after tax 161.3 189.1 Effect from IAS 29 on profit/loss after tax -0.6 5.0 Depreciation & amortization 105.9 94.4 Income tax expense 64.7 69.7 Income taxes paid -111.8 Net interest expense 24.9 Interest paid -20.2 (thereof interest paid for leases) (-4.
Slide 19: Cash flow statement (continued)
Financials Q2 2024: Cash flow statement (continued) in EURm Q2 2024 Q2 2023 Proceeds from the disposal of other financial assets - 0.1 Proceeds from the disposal of intangible assets and property, plant and equipment 44 Payments to acquire consolidated subsidiaries and other business units -23.4 Pay
Slide 20: Working capital
Financials Q2 2024: Working capital in EURm Inventories 1,539.9 + Trade receivables 2,549.8 ./. Trade payables 1,844.0 Working capital (end of pe: 2,245.7 Working capital turnover (annualized)?) 7.8x a 2 Based on fx. effects as of end of respective reporting period and incl. M&A 20 31 Mar 2024 1,422
Slide 21: Income statement 6M 2024
Financials 6M 2024: Income statement Sales 8,178.9 Cost of materials -6,165.1 Operating expenses -1,284.7 Depreciation -170.8 Net income / expense from sp. items -29.3 Amortization -29.1 Financial result “77.4 EBT 421.0 EPS 2.00 a 21 6M 2023 8,783.7 -6,717.3 2,066.4 -1,236.3 830.1 -152.8 677.3 -12.6
Slide 22: Segments 6M 2024
Financials 6M 2024: Segments inEURm Specialties Life Science 405.7 Specialties Material Science 167.3 Specialties Other 10.8 Essentials EMEA 498.3 Essentials North America 773.1 Essentials Latin America 114 Essentials APAC 72.6 Essentials Transregional 71 @ 2 Operating Gross Profit) 6M 2023 426.3 17
Slide 23: Operating EBITA bridges 6M 2024
Financials 6M 2024: Operating EBITA bridges” Operating EBITA growth inEURm = 6M 2023 FX translation M&A Organic contribution growth FX translation li M&A contribution 6M 2024 BB Organic Growth Operating EBITA growth by division inEURm -18% -18% -17% ; 6M 2023 Brenntag Brenntag Group and Specialties
Slide 24: Cash flow statement 6M 2024
Financials 6M 2024: Cash flow statement in EURm 6M 2024 6M 2023 Profit after tax 295.0 406.2 Effect from IAS 29 on profit/loss after tax 0.4 77 Depreciation & amortization 200.4 187.4 Income tax expense 126.0 149.5 Income taxes paid -127.7 -148.7 Net interest expense 62.1 Interest paid -63.8 (thereo
Slide 25: Cash flow statement (continued) 6M 2024
Financials 6M 2024: Cash flow statement (continued) in EURm Proceeds from the disposal of other financial assets Proceeds from the disposal of intangible assets and property, plant and equipment Payments to acquire consolidated subsidiaries and other business units Payments to acquire other financia
Slide 26: Free cash flow 6M 2024
Financials 6M 2024: Free cash flow Payments to acquire intangible assets and property, plant and equipment -146.8 A Working capita -160.8 Principal and interest payments on lease liabilities -87.2 G) 26 Based on average fx. rate excl. M&A 6M 2023 830.1 -100.8 227.5 -75.9 880.9 Aabs -102.5 -46.0 -388
Slide 27: Financial calendar / contact
Financial calendar / contact Financial calendar Contact Follow us: in| November 12, 2024 March 12, 2025 Brenntag SE Quarterly Statement Annual Report Corporate Investor Relations Q3 2024 FY 2024 Phone: +49 (0) 201 6496 2100 Fax: +49 (0) 201 6496 2003 May 14, 2025 May 22, 2025 Quarterly Statement Ann
Slide 28: Disclaimer
Disclaimer This presentation may contain forward-looking statements based on current assumptions and forecasts made by Brenntag SE and other information currently available to the company. Various known and unknown risks, uncertainties and other factors could lead to material differences between the